Skip to content
10-Q

Quarterly Report

BIOADAPTIVES, INC. BDPT

0001640334-24-001752

← back to feed
Filed
Nov 19, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 15, 2024 1.23B sh
Current Liabilities Q3 2024 · Sep 30, 2024 $1.85M
Current Liabilities Q3 2024 · Dec 31, 2023 $1.75M
Total Liabilities Q3 2024 · Sep 30, 2024 $1.85M
Total Liabilities Q3 2024 · Dec 31, 2023 $1.75M
Current Assets Q3 2024 · Sep 30, 2024 $46.39K
Current Assets Q3 2024 · Dec 31, 2023 $88.56K
Total Assets Q3 2024 · Sep 30, 2024 $46.39K
Total Assets Q3 2024 · Dec 31, 2023 $104K
Eps Basic Q3 2024 · Sep 30, 2024 $0.00
Eps Basic Q3 2024 · Sep 30, 2024 $0.00
Eps Basic Q3 2024 · Sep 30, 2023 $0.00
Eps Basic Q3 2024 · Sep 30, 2023 $0.00
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$132.48K
Stockholders Equity Q3 2024 · Sep 30, 2023 −$1.15M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$1.68M
Stockholders Equity Q3 2024 · Mar 31, 2023 −$1.63M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$1.45M
Sga Expense Q3 2024 · Sep 30, 2023 $33.71K
Sga Expense Q3 2024 · Sep 30, 2023 $60.26K
Net Income Q3 2024 · Sep 30, 2023 −$13.06K
Net Income Q3 2024 · Sep 30, 2023 −$444.17K
Net Income Q3 2024 · Jun 30, 2023 −$143.92K
Net Income Q3 2024 · Mar 31, 2023 −$287.19K
Operating Income Q3 2024 · Sep 30, 2023 −$92.21K
Operating Income Q3 2024 · Sep 30, 2023 −$167.14K
Gross Profit Q3 2024 · Sep 30, 2023 $4.65K
Gross Profit Q3 2024 · Sep 30, 2023 $8.12K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $11K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $13.24K
Revenue Q3 2024 · Sep 30, 2023 $15.65K
Revenue Q3 2024 · Sep 30, 2023 $21.36K